Halozyme Therapeutics
HALO
#2057
Rank
HK$58.45 B
Marketcap
HK$474.63
Share price
0.28%
Change (1 day)
46.72%
Change (1 year)

EPS for Halozyme Therapeutics (HALO)

EPS in 2023 (TTM): HK$13.64

According to Halozyme Therapeutics's latest financial reports the company's current EPS (TTM) is HK$13.53. In 2022 the company made an earnings per share (EPS) of HK$11.50 a decrease over its 2021 EPS that were of HK$22.15.

EPS history for Halozyme Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$13.6418.54%
2022HK$11.50-48.07%
2021HK$22.15196.88%
2020HK$7.46-292%
2019-HK$3.89-9.09%
2018-HK$4.28-237.5%
2017HK$3.11-149.38%
2016-HK$6.30211.54%
2015-HK$2.02-52.73%
2014-HK$4.28-24.66%
2013-HK$5.6748.98%
2012-HK$3.81145%
2011-HK$1.55-64.29%
2010-HK$4.35-17.65%
2009-HK$5.299.68%
2008-HK$4.8293.75%
2007-HK$2.4933.33%
2006-HK$1.87-4%
2005-HK$1.94-3.85%
2004-HK$2.02-13.33%
2003-HK$2.3383.59%
2002-HK$1.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$1.48-110.92%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$42.20 212.03%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$39.80 194.25%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$14.46 6.90%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$24.72 82.77%๐Ÿ‡ซ๐Ÿ‡ท France
HK$109.49 709.50%๐Ÿ‡บ๐Ÿ‡ธ USA